Moltkia coerulea extracts alleviate caspase-3 activity via reducing oxidative stress in LPS-induced neurotoxicity in BV-2 cells
Turkish Journal of Medical Sciences · 12.12.2025 · 55 (6) · 1584-1594
DOI: 10.55730/1300-0144.6117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 12.12.2025. Verfasst von Aslı Can Ağca und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional, Complementary and Integrative Medicine, Institute of Public Health, Ankara Yıldırım Beyazıt University, Ankara, Turkiye. Hauptthemen laut MEDLINE: Plant Extracts, Oxidative Stress, Caspase 3, Microglia. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: Moltkia coerulea, a medicinal plant traditionally used for its neuroprotective properties, contains diverse phenolic compounds. However, its mechanisms of action in neuroinflammation remain unclear. We hypothesized that extracts of M. coerulea may protect microglial cells from lipopolysaccharide (LPS)-induced oxidative stress and apoptosis by modulating reactive oxygen species (ROS) and caspase-3 activity. Materials and methods: Aqueous and methanol extracts (5–50 μg/mL) were tested in BV-2 microglial cells. Cell viability was assessed by MTT assay, while ROS generation and caspase-3 activity were measured using fluorescence-based kits. The effective concentration (10 μg/mL) was selected for mechanistic assays based on viability data and previous studies. The phenolic profile of the plant extracts was determined by liquid chromatography with tandem mass spectrometry (LC/MS/MS).
Results
Both extracts improved cell survival, reduced ROS levels, and attenuated caspase-3 activation in LPS-treated BV-2 cells. LC/MS/ MS analysis identified chlorogenic acid, rosmarinic acid, vanillin, and rutin as predominant in the methanolic extract, while chlorogenic acid and rutin were most abundant in the aqueous extract; all are associated with antioxidant and antiapoptotic potential.
Conclusion
M. coerulea extracts alleviated LPS-induced apoptosis in BV-2 cells by reducing oxidative stress and caspase-3 activity. These findings suggest a potential neuroprotective role of phenolic compounds present in M. coerulea that may translate into beneficial effects in animal models and warrant further preclinical evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional, Complementary and Integrative Medicine, Institute of Public Health, Ankara Yıldırım Beyazıt University, Ankara, Turkiye.
- Department of Medical Services and Techniques, Vocational School of Health Services, Ankara Yıldırım Beyazıt University, Ankara, Turkiye.
- Department of Medical Pharmacology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkiye.
- Department of Pharmacognosy, Faculty of Pharmacy, Ankara University, Ankara, Turkiye.
ORCID-Profile: Aslı Can Ağca, Derya Altay, Hüdaverdi Kul, Aslı F Ceylan, Betül Sever Yilmaz
Zitieren
APA
Can Ağca, A., Altay, D., Kul, H., Ceylan, A. F., & Sever Yilmaz, B. (2025). Moltkia coerulea extracts alleviate caspase-3 activity via reducing oxidative stress in LPS-induced neurotoxicity in BV-2 cells. Turkish Journal of Medical Sciences, 55(6), 1584-1594. https://doi.org/10.55730/1300-0144.6117
Vancouver
Can Ağca A, Altay D, Kul H, Ceylan AF, Sever Yilmaz B. Moltkia coerulea extracts alleviate caspase-3 activity via reducing oxidative stress in LPS-induced neurotoxicity in BV-2 cells. Turkish Journal of Medical Sciences. 2025;55(6):1584-1594. doi:10.55730/1300-0144.6117
BibTeX
@article{CanAca2025,
author = {Can Ağca, Aslı and Altay, Derya and Kul, Hüdaverdi and Ceylan, Aslı F and Sever Yilmaz, Betül},
title = {Moltkia coerulea extracts alleviate caspase-3 activity via reducing oxidative stress in LPS-induced neurotoxicity in BV-2 cells},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {6},
pages = {1584--1594},
doi = {10.55730/1300-0144.6117}
}
EUVIMED